Delivery Order EPD13009-0005

This contract was awarded by the Environmental Protection Agency (EPA) Office of Research and Development to Acea Biosciences, Inc., a small business, for the TOXCAST Program - Microelectronic Monitoring of Cellular Status. The contract has a firm fixed price of $897,658.00 and a completion date of May 10, 2018. Acea Biosciences is a life sciences company that provides specialized equipment and services related to flow cytometry, cell analysis, and biosensing technology. They have received...

<p>This is a task order awarded under contract EP-D-13-009 to Acea Biosciences, Inc., a small business, by the U.S. Environmental Protection Agency's Office of Research and Development. The task order, valued at $415,402.00, is for the identification of estrogen receptor agonists as part of the TOXCAST microelectronic monitoring of cellular status program. The contract is a firm fixed price delivery order.</p>

This is a firm fixed-price delivery order contract awarded by the Environmental Protection Agency's Office of Research and Development to Acea Biosciences, Inc., a small business, for $673,520.00. The contract is for the TOXCAST program, which focuses on the microelectronic monitoring of cellular status. The work will be performed in San Diego, California. Acea Biosciences has received over 20 prior federal contract awards from various agencies, demonstrating its capabilities in supplying...

This is a federal delivery order contract awarded by the U.S. Environmental Protection Agency (EPA) Office of Research and Development to Novascreen Biosciences Corporation, a for-profit small business. The $594,054.69 firm fixed-price contract is for bioactivity profiling of the ToxCast compound library, which is part of the EPA's ToxCast prioritization program. The contract does not have a set-aside designation. The contract was awarded on October 15, 2015 with a completion date of October 14,...

This is a firm fixed-price delivery order under the TOXCAST PRIORITIZATION program, awarded by the Environmental Protection Agency's (EPA) Office of Research and Development to Attagene Inc., a small disadvantaged business. The contract, valued at $100,224.00, requires Attagene to perform multiplexed transcription factor profiling of the TOXCAST compound library. This work supports the EPA's efforts to develop improved approaches for assessing the biological impacts of chemicals, with...

This federal contract award, valued at $330,000.00, was issued by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The contract, designated as a Small Business set-aside, supports the EPA's ToxCast program for high-throughput bioassay analysis of the ToxCast chemical library. Specifically, the work involves the reproducibility of cell fate trajectory analysis, which aids the EPA in...

This is a $50,000.00 firm-fixed-price purchase order awarded by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The contract is for testing of chemical compounds in a human neurite outgrowth assay as part of absorption, distribution, metabolism, and excretion (ADME) and toxicology (ADME-TOX) services. Cyprotex has significant expertise in predictive toxicology, ADME research, and in...

Cyprotex US LLC has been awarded a firm fixed price delivery order against its indefinite delivery indefinite quantity contract with the Environmental Protection Agency (EPA) to provide toxicokinetic testing services. The $133,690 order calls for Cyprotex to conduct toxicokinetic testing out of its Watertown, Massachusetts facility in support of the EPA Office of Research and Development's chemical risk assessment efforts. Through high-throughput in vitro assays on hundreds of industrial...

Medchemexpress LLC has been awarded a firm fixed price purchase order valued at $24,700 by the National Institutes of Health's National Center for Advancing Translational Sciences to provide 29 compounds in support of the agency's Tox21 research project examining the NS3-NS2B complex. As part of its mission to translate scientific discoveries into clinical applications, NCATS utilizes screening programs like Tox21 to evaluate the effects of environmental chemicals on biological pathways...

The Environmental Protection Agency awarded a $1.756 million firm fixed price delivery order contract to Cyprotex US LLC under the agency's HIGH THROUGHPUT TOXICOKINETICS program. The contract calls for Cyprotex to provide toxicokinetics services to the EPA from its location in Watertown, Massachusetts over an 11-month period ending in May 2021. As a leading provider of in vitro toxicology and ADMET screening assays, Cyprotex will leverage its expertise to support the EPA's work evaluating the...